Idézéskapcsolat

Shah P. et al. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. (2020) PHARMACEUTICS 1999-4923 1999-4923 12 3

Közlemény:
Katona Gábor et al. Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach. (2020) PHARMACEUTICS 1999-4923 1999-4923 12 2
Idéző közlemény:
Shah P. et al. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. (2020) PHARMACEUTICS 1999-4923 1999-4923 12 3
Független: Igen
2022-10-07 15:04